here are 4 mass. biotechs making noise at the ash conference so far
.
.
schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals."
.
people
.
'indian ip and liabilities law barrier to pharma r&d investment'
hbo to make documentary of ‘serial’ podcast’s adnan syed
.
featured programs
. 7 eco-friendly alternatives to plastic straws to help save the oceans
.consider making a donation to support the coverage that shapes the face of berkeley.
.activity
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
twenty students and two teachers at mt maria college were sent to hospital